One month after Amedisys agreed to be bought by at-home infusion giant Option Care Health  in a $3.6 billion all-stock deal, the home health company based in both Louisiana and Nashville announced it received an unsolicited all-cash offer for $3.26 billion from UnitedHealth Group. 

Optum, a subsidiary of UnitedHealth Group, made an offer of $100 per share, according to Amedisys, more than Option Care Health’s agreement to buy the company for roughly $97.38 per share. UnitedHealth Group’s all-cash proposal differs from Option Care Health’s, which opted to use stock as currency rather than raising cash. In the Option Care Health proposal, Amedisys stockholders would receive 3.0213 shares of Option Care Health’s common stock for each share of Amedisys common stock. 

Recommended for you